Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Oxidoreductases
Patent
1996-12-31
1999-11-16
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Oxidoreductases
424417, 424418, 435192, 435 691, 4352523, 4353201, 514 8, 536 232, A61K 3844, A61K 9127, C12N 908, C12N 1555
Patent
active
059852720
ABSTRACT:
Human myeloperoxidase produced by culturing prokaryotic or eukaryotic cells transformed by a vector for the expression of human myeloperoxidase in said cells.
REFERENCES:
patent: 4306025 (1981-12-01), Hasegawa et al.
patent: 4379141 (1983-04-01), Hasegawa et al.
patent: 4894443 (1990-01-01), Greenfield et al.
patent: 4943527 (1990-07-01), Protter et al.
patent: 5049493 (1991-09-01), Khosla et al.
patent: 5059528 (1991-10-01), Bollen et al.
patent: 5240831 (1993-08-01), Barnes eta l.
patent: 5460961 (1995-10-01), Deby et al.
Moguilevsky, N., et al., European Journal of Biochemistry, vol. 197, "Structural and biological properties of human recombinant myeloperoxidase produced by Chinese hamster ovary cell lines", pp. 605-614, 1991.
Matsuura, et al., Journal of General Virology, vol. 68, "Baculovirus expression vectors: The requirements for high level expression of proteins, including glycoproteins", pp. 1233-1250, 1987.
Morishita, K., et al., The Journal of Biological Chemistry, vol. 262, "Molecular cloning and characterization of cDNA for human myeloperoxidase", pp. 3844-3851, 1987.
Weil, S. C., et al., Proceedings of the national Academy of Sciences, U.S.A., vol. 84, "cDNA cloning of human myeloperoxidase: Decrease in myeloperoxidase mRNA upon induction of HL-60 cells", pp. 2057-2061, 1987.
Johnson, K. R., et al., Nucleic Acids Research, vol. 15, "Characterization of cDNA clones for human myeloperoxidase: predicted amino acid sequence and evidence for multiple mRNA species", pp. 2013-2028, 1987.
Yamada, M., et al., Archives of Biochemistry and Biophysics, vol. 255, "Isolation and characterization of a cDNA coding for human myeloperoxidase", pp. 147-155, 1987.
Morishita, K., et al., The Journal of Biological Chemistry, vol. 262, "Chromosomal gene structure of human myeloperoxidase and regulation of its expression by granulocyte colony-stimulating factor", pp. 15208-15203, 1987.
Hashinaka, K., et al., Biochemistry, vol. 27, "Multiple species of myeloperoxidase messenger RNAs produced by alternative splicing and differential polyadenylation", pp. 5906-5914, 1988.
Moguilevsky, N., et al., FEBS Letters, vol. 302, "Lethal oxidative damage to human immunodeficiency virus by human recombinant myeloperoxidase", pp. 209-212, 1992.
Tournay, C., et al., Antimicrobial Agents and Chemotherapy, vol. 37, "Candidacidal activity of the human recombinant myeloperoxidase system", pp. 142-143, 1993.
DHFR Coamplification of t-PA in DHFR.sup.+ Bovine Endothelial Cells: In vitro Characterization of the Purified Serine Protease, Connors et al., DNA. vol. 7, No. 9, 1988 pp. 651-661.
Spectral and Enzymatic Properties of human REcombinant Myeloperoxidase: Comparison with teh Mature Enzyme, Jacquet et al., Archives of Biochemistry and Biophysics, vol. 291, No. 1, Nov. 15, 1991, pp. 132-138.
Myeloperoxidase is synthesized as larger phosphorylated precursor, The EMBO Jornal, vol. 3, No. 11, 1984, pp. 2671-2676.
Identification and Properties of an Oxoferryl Structure in Myeloperoxidase Compound II, Oertling et al., Biochemistry 1988, vol. 27, pp. 5359-5400.
Expression of a Synthetic Gene for Horseradish Peroxidase C in Escherichia coli and Folding and Activation of the REcombinant Enzyme with Ca.sup.2 and Heme, Smith et al., The Journal of Biochemiustry, vol. 265, No. 22, Aug. 5, 1990, pp. 13335-13343.
Induction of nuetralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus, Massaer et al., Journal of General Virology 1993, vol. 74, pp. 491-494.
Expression of the human apolipoprotein AI gene fused to the E. coli gene for B-galactosidase, Lorenzetti et al., FEBS, vol. 194, No. 2 1986.
High-level Production of Fully Active Human .alpha.1-Antitrypsin in Escherichia coli, Johansen et al., Mol. Bio. Med. 1987, vol. 4, pp. 291-305.
Selection of Mutations that Increase .alpha.1-Antitrypsin Gene Expression in Excherichia coli, Sutiphong et al., Mol. Biol. Med. 1987, vol. 4, pp. 307-322.
Host System Pointers, Van Berunt, Biotechnology vol. 5, Jul. 1987, p. 664.
Synthesis and Localization of Myeloperoxidase Protein in Transfected BHK Cells, Cully et al., Experimental Cell Research 180, 1989 pp. 440-450.
Effect of nucleotide s=equences directly downstream from teh AUG on teh expression of bovine somatrotropin in E. coli, Tomich et al., Nucleic Acids REs. Apr. 25, 1989, vol. 17, No. 8, pp. 3179-3197 (Abstract Only).
Effect of von Willebrand factor coexpression on teh synthesis and secretion of factor VIII in Chinese hamster ovary cells, Kaufman et al., Mol. Cell Biol. Mar. 1989, vol. 9, No. 3, pp. 1233-1242 (Abstract Only).
Bollen Alex
Deby Carol
Pincemail Joel
Moore William W.
Universite Libre De Bruxelles
Wax Robert A.
LandOfFree
Human myeloperoxidase and its therapeutic application does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human myeloperoxidase and its therapeutic application, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human myeloperoxidase and its therapeutic application will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1320642